- Home
- AVR vs NVCT Comparison
AVR vs NVCT Comparison
Compare AVR & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- NVCT
- Stock Information
- Founded
- AVR 1999
- NVCT 2020
- Country
- AVR Australia
- NVCT United States
- Employees
- AVR N/A
- NVCT N/A
- Industry
- AVR
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- AVR
- NVCT Health Care
- Exchange
- AVR NYSE
- NVCT Nasdaq
- Market Cap
- AVR 241.5M
- NVCT 201.8M
- IPO Year
- AVR 2024
- NVCT 2022
- Fundamental
- Price
- AVR $4.53
- NVCT $8.90
- Analyst Decision
- AVR Strong Buy
- NVCT Strong Buy
- Analyst Count
- AVR 4
- NVCT 3
- Target Price
- AVR $16.50
- NVCT $17.00
- AVG Volume (30 Days)
- AVR 142.8K
- NVCT 133.2K
- Earning Date
- AVR 05-13-2025
- NVCT 05-06-2025
- Dividend Yield
- AVR N/A
- NVCT N/A
- EPS Growth
- AVR N/A
- NVCT N/A
- EPS
- AVR N/A
- NVCT N/A
- Revenue
- AVR $2,493,000.00
- NVCT N/A
- Revenue This Year
- AVR $29.52
- NVCT N/A
- Revenue Next Year
- AVR $204.83
- NVCT N/A
- P/E Ratio
- AVR N/A
- NVCT N/A
- Revenue Growth
- AVR N/A
- NVCT N/A
- 52 Week Low
- AVR $2.34
- NVCT $4.44
- 52 Week High
- AVR $8.79
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- NVCT 46.25
- Support Level
- AVR N/A
- NVCT $8.65
- Resistance Level
- AVR N/A
- NVCT $9.75
- Average True Range (ATR)
- AVR 0.00
- NVCT 0.60
- MACD
- AVR 0.00
- NVCT -0.11
- Stochastic Oscillator
- AVR 0.00
- NVCT 18.65
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.